No | Title | Authors | Year |
---|
1 | Do targeted HIV programs improve overall care for pregnant women? Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs | Potter D, Goldenberg RL, Chao A, Sinkala M, Degroot A, Stringer JSA, Bulterys M, Vermund SH | 2008 |
2 | A pilot study of food supplementation to improve adherence to antiretroviral therapy among food insecure adults in Lusaka, Zambia | Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, Stringer JSA | 2008 |
3 | Abandonment of antiretroviral therapy for local AIDS remedies: a potential barrier to scale-up in sub-Saharan Africa | Reid SE, Mulenga LB, Folk WR, Tambatamba BC, Chi BH | 2008 |
4 | Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission | Chi BH, Chintu N, Cantrell RA, Kankasa C, Kruse G, Mbewe F, Sinkala M, Smith PJ, Stringer EM, Stringer JSA | 2008 |
5 | Baseline renal insufficiency and risk of death among HIV-infected adults initiating antiretroviral therapy in Lusaka, Zambia | Mulenga L, Kruse G, Lakhi S, Cantrell RA, Reid S, Zulu I, Stringer EM, Krishnasami Z, Mwinga A, Saag MS, Stringer JSA, Chi BH | 2008 |
6 | Community-based follow-up for late patients enrolled in a district-wide program for antiretroviral therapy in Lusaka, Zambia | Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JSA | 2008 |
7 | Declining HIV prevalence among young pregnant women in Lusaka, Zambia, 2002-2006 | Stringer EM, Chintu N, Levy J, Sinkala M, Chi BH, Muyanga J, Bulterys M, Megazzini K, Stringer JSA | 2008 |
8 | Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period | Brown E, Chi BH, Read JSA, Taha TE, Sharma U, Hoffman IF, Goldenberg RL, Fiscus SA | 2008 |
9 | Early lessons from integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia | Harris JB, Hatwiinda S, Randels KM, Chi BH, Kancheya NG, Jham MA, Samungole KVG, Tambatamba BC, Cantrell RA, Levy JW, Kimerling ME, Reid SE | 2008 |
10 | Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial | Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L; HPTN 039 Protocol Team | 2008 |
11 | Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa | Sutcliffe CG, van Kijk JH, Bolton C, Persaud D, Moss WJ | 2008 |
12 | Extended nevirapine prophylaxis to prevent HIV transmission | Stringer JSA, Chi BH | 2008 |
13 | Hormonal contraception and HIV disease progression | Stringer E, Antonsen E | 2008 |
14 | Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes | Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JSA, Parham GP | 2008 |
15 | Management of cryotherapy-ineligible women in a “see and treat” cervical cancer program targeting HIV-infected women in Zambia: lessons from the field | Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JSA, Parham GP | 2008 |
16 | Monitoring effectiveness of programs to prevent mother-to-child HIV transmission in lower-income countries | Stringer EM, Chi BH, Chintu N, Creek T, Ekouvie D, Coetzee D, Tih P, Boulle A, Dabis F, Shaffer N, Wilfert CM, Stringer JSA | 2008 |
17 | Risk factors for late post-natal transmission of human immunodeficiency virus type 1 | Chasela C, Chen YQ, Fiscus S, Hoffman I, Young A, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JSA | 2008 |
18 | Simple adherence measures to predict virologic suppression among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy | Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JSA, Chi BH | 2008 |
19 | The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study | Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B, HPTN 055 Study Team | 2008 |